Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Cidara Therapeutics, Inc. - Common Stock
(NQ:
CDTX
)
61.85
-0.97 (-1.54%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 25, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Cidara Therapeutics, Inc. - Common Stock
< Previous
1
2
3
4
5
Next >
Biotech Catalyst Alert: NKTR, CDTX & WGS Rallying With Big Gains
June 30, 2025
With major rallies and analyst backing, Nektar, Cidara, and GeneDx are drawing interest; will these biopharma firms maintain their growth trajectories?
Via
MarketBeat
FedEx Issues Soft Guidance, Joins Torrid Holdings, Allot And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
June 25, 2025
Via
Benzinga
Why BlackBerry Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
June 25, 2025
Via
Benzinga
Applied Materials To Rally Around 28%? Here Are 10 Top Analyst Forecasts For Tuesday
June 24, 2025
Via
Benzinga
Earnings Scheduled For May 8, 2025
May 08, 2025
Via
Benzinga
Why Cidara Therapeutics (CDTX) Stock Is Falling
April 22, 2024
Cidara Therapeutics shares are trading lower by 24.4% Monday afternoon. The company announced a 1-for-20 reverse stock split.
Via
Benzinga
Cidara Therapeutics Stock Jumps After-Hours As Strong Flu Trial Data Outweighs $250M Share Offering
June 23, 2025
The offering is being led by J.P. Morgan, Morgan Stanley, Guggenheim Securities, and Cantor.
Via
Stocktwits
What's going on in today's session
June 23, 2025
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via
Chartmill
Cidara Therapeutics’ Market Cap Doubles After Investigational Drug Shows Positive Results In Preventing Influenza In Mid-stage Trial
June 23, 2025
Single doses of 450mg, 300mg, and 150mg of CD388 conferred 76%, 61%, and 58% protection, respectively, from symptomatic influenza over 24 weeks compared to placebo, the company said.
Via
Stocktwits
12 Health Care Stocks Moving In Monday's Intraday Session
June 23, 2025
Via
Benzinga
Crude Oil Falls 1%; US Services PMI Declines In June
June 23, 2025
Via
Benzinga
Which stocks are experiencing notable movement on Monday?
June 23, 2025
Stay up-to-date with the latest market trends in the middle of the day on Monday. Explore the top gainers and losers during today's session in our detailed report.
Via
Chartmill
Cidara Launches 93% As A Universal Flu Shot Becomes A Closer Reality
June 23, 2025
The midstage study hit all its goals, representing a "best case" scenario, according to one analyst.
Via
Investor's Business Daily
Why Is Cidara Therapeutics Stock Trading Higher On Monday?
June 23, 2025
Cidara's CD388 met key goals in a Phase 2b flu trial, showing strong efficacy and safety data, with FDA talks planned for advancing to Phase 3.
Via
Benzinga
Dow Jumps Over 200 Points; FactSet Research Shares Gain After Q3 Results
June 23, 2025
Via
Benzinga
Topics
Stocks
These stocks are gapping in today's session
June 23, 2025
There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Monday.
Via
Chartmill
These stocks are moving in today's pre-market session
June 23, 2025
Discover the top movers in Monday's pre-market session and stay informed about market dynamics.
Via
Chartmill
12 Health Care Stocks Moving In Monday's Pre-Market Session
June 23, 2025
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
November 21, 2024
Via
Benzinga
Cidara Therapeutics' Unique Cloudbreak Platform And Its Promise In Influenza And Oncology
November 14, 2024
CDTX sold its Rezayo business to concentrate on its MDC-producing Cloudbreak platform which has already produced several promising drug candidates, like CD388, a very promising clinical-stage...
Via
Talk Markets
This Cytokinetics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
November 08, 2024
Via
Benzinga
CDTX Stock Earnings: Cidara Therapeutics Beats EPS, Misses Revenue for Q2 2024
August 13, 2024
CDTX stock results show that Cidara Therapeutics beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
Via
InvestorPlace
CDTX Stock Earnings: Cidara Therapeutics Misses EPS, Misses Revenue for Q1 2024
May 15, 2024
CDTX stock results show that Cidara Therapeutics missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
Via
InvestorPlace
Why Caterpillar Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
April 25, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
April 25, 2024
Pre-market stock movers are a great way to start Thursday as we check out all of the hottest news moving shares this morning!
Via
InvestorPlace
Why Teradyne Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket
April 25, 2024
Via
Benzinga
Why Nucor Shares Are Trading Lower? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
April 23, 2024
Via
Benzinga
Why Hibbett Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket
April 23, 2024
Via
Benzinga
CDTX Stock Earnings: Cidara Therapeutics Beats EPS, Beats Revenue for Q4 2023
April 22, 2024
CDTX stock results show that Cidara Therapeutics beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's After-Market Session
February 14, 2024
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.